BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12865892)

  • 1. Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid.
    Schwieler L; Erhardt S
    Neuropsychopharmacology; 2003 Oct; 28(10):1770-7. PubMed ID: 12865892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.
    Schwieler L; Engberg G; Erhardt S
    Synapse; 2004 May; 52(2):114-22. PubMed ID: 15034917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
    Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
    Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
    Erhardt S; Engberg G
    Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area.
    Schwieler L; Linderholm KR; Nilsson-Todd LK; Erhardt S; Engberg G
    Life Sci; 2008 Aug; 83(5-6):170-5. PubMed ID: 18590745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid.
    Schwieler L; Erhardt S; Nilsson L; Linderholm K; Engberg G
    Synapse; 2006 Apr; 59(5):290-8. PubMed ID: 16416446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine blocks D-amphetamine-induced excitation of dopamine neurons in the ventral tegmental area.
    Shi WX; Zhang XY; Pun CL; Bunney BS
    Neuropsychopharmacology; 2007 Sep; 32(9):1922-8. PubMed ID: 17299514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms.
    Nilsson LK; Schwieler L; Engberg G; Linderholm KR; Erhardt S
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):329-39. PubMed ID: 15737250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.
    Erhardt S; Schwieler L; Engberg G
    Synapse; 2002 Mar; 43(4):227-37. PubMed ID: 11835517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous kynurenic acid disrupts prepulse inhibition.
    Erhardt S; Schwieler L; Emanuelsson C; Geyer M
    Biol Psychiatry; 2004 Aug; 56(4):255-60. PubMed ID: 15312813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
    Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kynurenic acid and schizophrenia.
    Erhardt S; Schwieler L; Engberg G
    Adv Exp Med Biol; 2003; 527():155-65. PubMed ID: 15206728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
    Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
    Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
    Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
    Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
    Etievant A; Bétry C; Arnt J; Haddjeri N
    Neurosci Lett; 2009 Aug; 460(1):82-6. PubMed ID: 19450663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo.
    Erhardt S; Mathé JM; Chergui K; Engberg G; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):173-80. PubMed ID: 11882912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Watanabe KI; Ashby CR
    Synapse; 2001 May; 40(2):102-12. PubMed ID: 11252021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia.
    Tufvesson-Alm M; Schwieler L; Schwarcz R; Goiny M; Erhardt S; Engberg G
    Neuropharmacology; 2018 Aug; 138():130-139. PubMed ID: 29879409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
    Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M
    Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway.
    Valenti O; Grace AA
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):845-60. PubMed ID: 19751544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.